A new study published by the Oxford journal Carcinogenesis, and published online by the U.S. National Institute of Health, has found that the cannabis compound cannabigerol can prevent the progression of cancer cells formed in the colon.

“Cannabigerol (CBG) is a safe non-psychotropic Cannabis-derived cannabinoid which interacts with specific targets involved in carcinogenesis [the creation of cancer cells]“, begins the study’s abstract. “Here, we investigated whether CBG protects against colon tumorigenesis.”

After studying the effect of CBG on colon cancer cells, researchers found that; “In vivo, CBG inhibited the growth of xenograft tumors as well as chemically-induced colon carcinogenesis. CBG hampers colon cancer progression in vivo and selectively inhibits the growth of colorectal cancer cells.”

They study concludes; “CBG should be considered translationally in colorectal cancer prevention and cure.”

Another new study published in a recent issue of the journal Phytomedicine, and published online by the National Institute of Health, has found that cannabis-based medicines may provide a cure for colon cancer.

For the study, researchers “investigated the effect of a standardized Cannabis sativa extract with high content of cannabidiol (CBD), here named CBD BDS, i.e. CBD botanical drug substance, on colorectal cancer cell proliferation and in experimental models of colon cancer in vivo.”

While conducting the study, it was found that; “CBD reduced cell proliferation in tumoral, but not in healthy, cells. In vivo, CBD reduced AOM-induced preneoplastic lesions and polyps as well as tumour growth in the xenograft model of colon cancer.”

Researchers conclude that “CBD attenuates colon carcinogenesis and inhibits colorectal cancer cell proliferation via CB1 and CB2 receptor activation. The results may have some clinical relevance for the use of Cannabis-based medicines in cancer patients.”

The study was conducted by researchers at the University of Naples Federico II in Italy and the University of Aberdeen in the United Kingdom.